You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
The Food and Drug Administration has given marketing clearance to Bayer Corporation's pharmaceutical division to use Precose in combination with insulin or metformin for treating people with type 2 diabetes.
Precose, which is also known as acarbose, is an oral agent that works in the small intestine by delaying carbohydrate digestion and glucose absorption.
According to news wire reports, the FDA has given clearance for the use of Precose for people with type 2 diabetes whose postmeal blood sugars and long-term HbA1cs are not adequately controlled by insulin or metformin (also known as Glucophage).
"The UKPDS clearly indicates that the use of a single medication to control blood glucose levels and complications associated with diabetes may be inadequate," says James Magner, MD, deputy director of metabolics, Bayer pharmaceutical division. "Precose can be used safely in combination therapy with minimal side effects. We see this as being key to the future of diabetes management."
Common side effects associated with taking Precose include flatulence, abdominal pain and diarrhea.
Jan 1, 1999
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.